Literature DB >> 1764393

Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies.

A M Nouri1, A V dos Santos, D Crosby, R T Oliver.   

Abstract

Analysis of tissue sections from transurethrally resected bladder tumours using anti-CD3 antibody showed the presence of T lymphocytes in intra-epithelial layers in eight of 12 cases investigated. In a larger group of patients, Tumour Infiltrating Lymphocyte (TIL) growth was established from six of 19 cases using Interleukin-2 (IL-2) and conditioned medium (CM) and resulted in the expansion of TILs up to 100-fold. TILs from these individuals were phenotyped with W6/32 (anti-HLA-A,B,C), HB55 (anti-DR) and anti-CD3 antibodies using FAC sorter. The mean +/- s.d. frequency of positive staining with these antibodies were 96.7 +/- 4.0%, 87.5 +/- 10.0% and 82.5 +/- 7.8% respectively, indicating the activated nature of these T cells. The cytotoxic activity of these TILs against Daudi (ie, LAK activity) cell line at 25/1 E/T ratios varied from 26.3 +/- 3.2 to 62.8 +/- 5.2%. In one case where TILs and autologous tumour cell line were established, cytotoxicity studies showed low level of cytotoxicity against the autologous tumour cells (15.8 +/- 1.6%) compared with 62.8 +/- 5.2% against Daudi. Staining of tumour sections from these 19 individuals with W6/32 and BBM.1 revealed positive staining in six of six that developed TILs but only six of 13 (46%) cases, whose tumour failed to grow TILs (P less than 0.02, Fisher exact test). These results are indicative of the presence of IL-2 passageable T cells in bladder cancer biopsy and demonstrate that the successful expansion of these cells correlates with the normal expression of class I antigens on the tumour cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764393      PMCID: PMC1977854          DOI: 10.1038/bjc.1991.454

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  AN IMMUNE REACTION IN MAN AGAINST SEMINOMAS, DYSGERMINOMAS, PINEALOMAS, AND THE MEDIASTINAL TUMOURS OF SIMILAR HISTOLOGICAL APPEARANCE?

Authors:  A H MARSHALL; A D DAYAN
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

2.  Topical BCG for recurrent superficial bladder cancer.

Authors: 
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

3.  Paired tumour infiltrating lymphocyte (TIL) and tumour cell line from bladder cancer: a new approach to study tumour immunology in vitro.

Authors:  A M Nouri; A Bergbaum; E Lederer; D Crosby; A Shamsa; R T Oliver
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

4.  Development of bladder tumour containing HPV type 11 DNA after renal transplantation.

Authors:  G Querci della Rovere; R T Oliver; D J McCance; J E Castro
Journal:  Br J Urol       Date:  1988-07

5.  Immunohistochemical detection of tissue-infiltrating lymphocytes in bladder tumors.

Authors:  H Tsujihashi; S Uejima; T Akiyama; T Kurita
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

6.  Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation.

Authors:  P Bryant; P Davies; D Wilson
Journal:  Br J Urol       Date:  1991-07

7.  Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.

Authors:  S L Topalian; L M Muul; D Solomon; S A Rosenberg
Journal:  J Immunol Methods       Date:  1987-08-24       Impact factor: 2.303

8.  Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.

Authors:  K Hui; F Grosveld; H Festenstein
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

Review 9.  Biological significance of beta hCG, HLA and other membrane antigen expression on bladder tumours and their relationship to tumour infiltrating lymphocytes (TIL).

Authors:  R T Oliver; A M Nouri; D Crosby; R L Iles; C Navarette; J Martin; W Bodmer; H Festenstein
Journal:  J Immunogenet       Date:  1989 Aug-Oct

10.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  1 in total

1.  Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.

Authors:  A M Nouri; E Dorey; C L Davis; A Rohatiner; T A Lister; R T Oliver
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.